M. Pérol
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 190
- Lung Cancer Diagnosis and Treatment 65
- Oncology 156
- Lung Cancer Research Studies 76
- Colorectal Cancer Treatments and Studies 36
- Cancer Immunotherapy and Biomarkers 32
- HER2/EGFR in Cancer Research 19
- Co-authors
- Solange Peters (20 shared papers)Rafael Rosell (10 shared papers)Tony Mok (13 shared papers)Shirish M. Gadgeel (15 shared papers)D. Ross Camidge (14 shared papers)Rafał Dziadziuszko (11 shared papers)Jin Seok Ahn (4 shared papers)Johannes Noé (4 shared papers)
- Journals
- Journal of Clinical Oncology (50 papers)Annals of Oncology (50 papers)Lung Cancer (32 papers)Journal of Thoracic Oncology (27 papers)Clinical Lung Cancer (8 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
M. Pérol
275 papers receiving 7.2k citations
M. Pérol's Hit Papers
Peers
Comparison fields: 5 of 118
- Pulmonary and Respiratory Medicine 4.7k
- Oncology 3.5k
- Cancer Research 950
- Genetics 256
- Pathology and Forensic Medicine 347
Countries citing papers authored by M. Pérol
This map shows the geographic impact of M. Pérol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Pérol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Pérol more than expected).
Fields of papers citing papers by M. Pérol
This network shows the impact of papers produced by M. Pérol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Pérol. The network helps show where M. Pérol may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Pérol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 295 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 1687 |
| 2 | 2005 | 434 | |
| 3 | Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study Hit paper breakdown → | 2020 | 429 |
| 4 | Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018 Hit paper breakdown → | 2020 | 223 |
| 5 | 2018 | 223 | |
| 6 | 2007 | 216 | |
| 7 | 2001 | 213 | |
| 8 | 2005 | 199 | |
| 9 | 2005 | 181 | |
| 10 | 2012 | 170 | |
| 11 | 2017 | 145 | |
| 12 | 2005 | 127 | |
| 13 | 2016 | 119 | |
| 14 | 2015 | 102 | |
| 15 | 2020 | 97 | |
| 16 | Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. | 2005 | 96 |
| 17 | 2003 | 92 | |
| 18 | 1997 | 80 | |
| 19 | 2010 | 72 | |
| 20 | 2022 | 60 |
About M. Pérol
M. Pérol is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 295 papers that have together received 7.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (190 papers), Lung Cancer Research Studies (76 papers), Lung Cancer Diagnosis and Treatment (65 papers), Colorectal Cancer Treatments and Studies (36 papers), Cancer Immunotherapy and Biomarkers (32 papers), Cancer Genomics and Diagnostics (27 papers), HER2/EGFR in Cancer Research (19 papers) and Cancer therapeutics and mechanisms (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.7k citations), Oncology (3.5k citations), Cancer Research (950 citations), Genetics (256 citations) and Pathology and Forensic Medicine (347 citations). M. Pérol has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Solange Peters, Rafael Rosell, Tony Mok, Shirish M. Gadgeel, D. Ross Camidge, Rafał Dziadziuszko, Jin Seok Ahn, Johannes Noé, Alice T. Shaw and Sai‐Hong Ignatius Ou. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, Journal of Thoracic Oncology and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.